← Back to Search

Behavioral Intervention

Family-Centered Care for Domestic Violence

N/A
Recruiting
Led By Gunjan Tiyyagura, MD, MHS
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a child < 3-years-old who been reported to Child Protectives Services for IPV exposure
Able to speak English or Spanish fluently
Must not have
Language preference other than English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year post visit 1, until child is 2 years of age
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how different approaches to care for families affected by IPV can affect caregivers, children, and outcomes.

Who is the study for?
This trial is for parents over 18 with a child under 3 who's been exposed to domestic violence and reported to Child Protective Services. Participants must speak English or Spanish, agree to a medical evaluation for the child, and not already be connected to an IPV advocate or be a ward of the state.
What is being tested?
The study compares Family-Centered Care (FCC) with Child-centered care (CCC) in terms of how they affect caregiver engagement in community services, feelings of empowerment, and clinical outcomes for children who have witnessed domestic violence.
What are the potential side effects?
Since this trial involves care models rather than medications, traditional side effects are not applicable. However, participants may experience emotional discomfort or stress due to discussions about intimate partner violence.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child under 3 has been reported to CPS due to exposure to IPV.
Select...
I am fluent in English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I prefer to communicate in a language other than English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year post visit 1, until child is 2 years of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year post visit 1, until child is 2 years of age for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percentage of caregivers with follow-up visits with an IPV advocate
Secondary study objectives
Frequency of IPV-related episodes assessed using the Conflict Tactic Scale 2 (CTS2) for partner's behaviors
Frequency of IPV-related episodes assessed using the Psychological Maltreatment of Women Inventory (PMWI)- Short form
Immunization status determined by the number of participants that received all recommended vaccinations
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FCC modelExperimental Treatment1 Intervention
Participants will receive family-focused care.
Group II: CCC modelActive Control1 Intervention
Participants will receive the usual child-focused care.

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,053 Previous Clinical Trials
2,731,333 Total Patients Enrolled
Yale UniversityLead Sponsor
1,920 Previous Clinical Trials
3,031,148 Total Patients Enrolled
Gunjan Tiyyagura, MD, MHSPrincipal InvestigatorYale University
~223 spots leftby Feb 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top